Search

everythinglearnresearchcommunity

for

Search:↓

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Some drugs used to treat inflammation may cause hair loss.

An enzyme other than TNAP might be responsible for vitamin B-6 metabolism in the skin.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Mutations in certain receptors can cause diseases and offer new treatment options.

Particle properties affect drug retention and release in minoxidil foams, with lipid nanoparticles having higher loading capacity.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Nanotechnology improves minoxidil treatment for hair loss.

Pseudomonas sp. T5-6-I bacteria increase selenium uptake in Brassica oleracea plants by 130%.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Minoxidil in breast milk may harm nursing infants.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

New drugs are improving treatment for hormone-related diseases in small pets.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.